Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX

MLA

Michael Z. Liao, et al. “Ethnic Sensitivity Assessment: Polatuzumab Vedotin Pharmacokinetics in Asian and Non‐Asian Patients with Previously Untreated Diffuse Large B‐cell Lymphoma in POLARIX.” Clinical and Translational Science, vol. 16, no. 12, Dec. 2023, pp. 2744–55. EBSCOhost, https://doi.org/10.1111/cts.13669.

APA

Michael Z. Liao, Rong Deng, Leonid Gibiansky, Tong Lu, Priya Agarwal, Randall Dere, Calvin Lee, Jamie Hirata, Charles Herbaux, Gilles Salles, Chunze Li, & Dale Miles. (2023). Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX. Clinical and Translational Science, 16(12), 2744–2755. https://doi.org/10.1111/cts.13669

Chicago

Michael Z. Liao, Rong Deng, Leonid Gibiansky, Tong Lu, Priya Agarwal, Randall Dere, Calvin Lee, et al. 2023. “Ethnic Sensitivity Assessment: Polatuzumab Vedotin Pharmacokinetics in Asian and Non‐Asian Patients with Previously Untreated Diffuse Large B‐cell Lymphoma in POLARIX.” Clinical and Translational Science 16 (12): 2744–55. doi:10.1111/cts.13669.